About Us

DiaPrep System Inc. (DiaPrep) is an alliance of partner organizations engaged in epidemiological research, infectious diseases diagnostic tool development, education, and consulting within the framework of programs aimed at improving public health, primarily, but not exclusively, in the countries of Eastern Europe and Central Asia. 

Founded in Atlanta, Georgia, in the United States, in 1996, it offers consulting on issues associated with public health and provides a range of support services to governments, public health agencies, manufacturers, and the medical community in their efforts to develop, evaluate, improve, and introduce programs, diagnostic test systems, strategies, and testing algorithms to control COVID-19, HIV, hepatitis viruses, and other diseases. 

In all it does, DiaPrep relies on well-grounded evidence and scientific practices informed by years of practical experience. In areas with limited resources, we help find affordable solutions to establish high-quality, accessible, and reliable laboratory diagnostics and rapid point-of-care testing.

DiaPrep partners with diagnostic test system manufacturers whose tests bear Europe’s CE Mark, certifying their compliance with European Economic Area health, safety, and environmental protection standards.

DiaPrep and our DIA Group partner organizations are actively engaged in projects to promote the diagnosis, monitoring, and prevention of COVID-19, including the development of serological antibody and antigen tests and their introduction into public health systems. We are also developing a vaccine against COVID-19.